Selection of estrogen receptor β- and thyroid hormone receptor β-specific coactivator-mimetic peptides using recombinant peptide libraries

被引:46
|
作者
Northrop, JP
Nguyen, D
Piplani, S
Olivan, SE
Kwan, STS
Go, NF
Hart, CP
Schatz, PJ
机构
[1] Affymax Research Institute, Santa Clara
[2] Affymax Research Institute, 3410 Central Expressway, Santa Clara
关键词
D O I
10.1210/me.14.5.605
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Steroid and thyroid hormone receptors are members of the superfamily of nuclear receptors (NR) that participate in developmental and homeostatic mechanisms by changes in the transcription of specific genes. These activities are governed by the receptors' cognate ligands and through interaction with the components of the transcriptional machinery. A number of coactivator molecules of the steroid receptor coactivator (SRC)/nuclear receptor coactivator (NCoA) family interact with activation functions within NRs through a conserved region containing helical domains of a core LXXLL sequence and, thereby, participate in transcriptional regulation. Using a mammalian-two-hybrid assay, we show that the thyroid hormone receptor beta (TR beta) and estrogen receptor beta (ER beta) have different LXXLL motif preferences for interactions with SRC-1. Using large random and focused (centered on the LXXLL motif) recombinant peptide diversity libraries, we have obtained novel peptide sequences that interact specifically with ER beta or with TR beta in a ligand-dependent manner. Random sequence libraries yielded LXXLL-containing peptides, and sequence analysis of selected clones revealed that the preferred residues within and around the LXXLL motif vary significantly between these two receptors. We compared the receptor binding of library-selected peptides to that of peptides derived from natural coactivators. The affinities of selected peptides for the ligand binding domains of ER beta and TR beta were similar to the best natural LXXLL motifs tested, but showed a higher degree of receptor selectivity. These selected peptides also display receptor-selective dominant inhibitory activities when introduced into mammalian cells. Finally, by directed mutations in specific residues, we were able to alter the receptor binding preference of these peptides.
引用
收藏
页码:605 / 622
页数:18
相关论文
共 24 条
  • [21] Identification of a novel peptide ligand for the cancer-specific receptor mutation EGFRvIII using high-throughput sequencing of phage-selected peptides
    Sourour Mansour
    Indranil Adhya
    Coralie Lebleu
    Rama Dumpati
    Ahmed Rehan
    Santu Chall
    Jingqi Dai
    Gauthier Errasti
    Thomas Delacroix
    Raj Chakrabarti
    Scientific Reports, 12
  • [22] Identification of a novel peptide ligand for the cancer-specific receptor mutation EGFRvIII using high-throughput sequencing of phage-selected peptides
    Mansour, Sourour
    Adhya, Indranil
    Lebleu, Coralie
    Dumpati, Rama
    Rehan, Ahmed
    Chall, Santu
    Dai, Jingqi
    Errasti, Gauthier
    Delacroix, Thomas
    Chakrabarti, Raj
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [23] IDENTIFICATION OF THYROID-STIMULATING HORMONE RECEPTOR-SPECIFIC T-CELLS IN GRAVES-DISEASE THYROID USING AUTOANTIGEN-TRANSFECTED EPSTEIN-BARR VIRUS-TRANSFORMED B-CELL LINES
    MULLINS, RJ
    COHEN, SBA
    WEBB, LMC
    CHERNAJOVSKY, Y
    DAYAN, CM
    LONDEI, M
    FELDMANN, M
    JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (01): : 30 - 37
  • [24] Selection and encephalitogenic potential of T-cells specific for myelin basic protein peptide [amino acids 111-129] using transgenic mouse with HLA-DRB1*0401-IE and chimeric human T cell receptor.
    Baig, MN
    Shukaliak, J
    Yao, K
    Ludwin, S
    Muraro, P
    Martin, R
    McFarland, H
    Ito, K
    AMERICAN JOURNAL OF HUMAN GENETICS, 2001, 69 (04) : 211 - 211